PetVivo Holdings, Inc. (PETV)
USD 0.61
(-3.48%)
USD 0.61
(-3.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 390.07 Thousand USD | 5.35% |
| 2023 | 370.28 Thousand USD | 276.64% |
| 2022 | 98.31 Thousand USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -53.5 Thousand USD | -528.17% |
| 2019 | 12.49 Thousand USD | -51.1% |
| 2018 | 25.55 Thousand USD | 0.0% |
| 2017 | - USD | 100.0% |
| 2016 | -15.9 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 100.0% |
| 2013 | -1231.00 USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 434.08 Thousand USD | 6.91% |
| 2024 Q3 | 467.46 Thousand USD | 7.69% |
| 2024 Q4 | 390.07 Thousand USD | -16.56% |
| 2024 FY | 390.07 Thousand USD | 5.35% |
| 2024 Q1 | 406.03 Thousand USD | 9.65% |
| 2023 Q1 | 180.87 Thousand USD | 83.98% |
| 2023 Q2 | 304.96 Thousand USD | 68.61% |
| 2023 Q4 | 370.28 Thousand USD | -1.23% |
| 2023 FY | 370.28 Thousand USD | 276.64% |
| 2023 Q3 | 374.88 Thousand USD | 22.93% |
| 2022 Q4 | 98.31 Thousand USD | -6.34% |
| 2022 FY | 98.31 Thousand USD | 0.0% |
| 2022 Q2 | 74.63 Thousand USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q3 | 104.96 Thousand USD | 40.63% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q3 | 9971.00 USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | - USD | -100.0% |
| 2020 Q4 | - USD | -100.0% |
| 2020 Q1 | 12.49 Thousand USD | 0.0% |
| 2020 Q2 | 12.49 Thousand USD | 0.0% |
| 2020 Q3 | 12.49 Thousand USD | 0.0% |
| 2020 FY | -53.5 Thousand USD | -528.17% |
| 2019 Q4 | 12.49 Thousand USD | -74.06% |
| 2019 Q3 | 48.16 Thousand USD | -16.64% |
| 2019 Q2 | 57.77 Thousand USD | -44.6% |
| 2019 Q1 | 104.28 Thousand USD | 308.09% |
| 2019 FY | 12.49 Thousand USD | -51.1% |
| 2018 FY | 25.55 Thousand USD | 0.0% |
| 2018 Q4 | 25.55 Thousand USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 100.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | -15.9 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 100.0% |
| 2014 Q3 | - USD | 100.0% |
| 2014 Q2 | -1562.00 USD | -9.0% |
| 2014 Q1 | -1433.00 USD | -16.41% |
| 2014 Q4 | - USD | 0.0% |
| 2013 FY | -1231.00 USD | 0.0% |
| 2013 Q1 | -1216.00 USD | 0.0% |
| 2013 Q3 | -51.46 Thousand USD | -3825.4% |
| 2013 Q4 | -1231.00 USD | 97.61% |
| 2013 Q2 | -1311.00 USD | -7.81% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 88.215% |
| BrainsWay Ltd. | 3.71 Million USD | 89.506% |
| Cerus Corporation | 39.86 Million USD | 99.022% |
| Envoy Medical, Inc. | 1.4 Million USD | 72.217% |
| electroCore, Inc. | 2.16 Million USD | 81.941% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | 14.644% |
| IceCure Medical Ltd | 2.27 Million USD | 82.854% |
| Inogen, Inc. | 21.84 Million USD | 98.214% |
| OrthoPediatrics Corp. | 105.85 Million USD | 99.631% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -40.315% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -39007500.0% |
| MaxCyte, Inc. | 12.22 Million USD | 96.81% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | 77.409% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -149.377% |
| Orthofix Medical Inc. | 222.16 Million USD | 99.824% |
| PAVmed Inc | 1.01 Million USD | 61.644% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 98.046% |
| RxSight, Inc. | 17.42 Million USD | 97.761% |
| Sight Sciences, Inc. | 7.84 Million USD | 95.03% |
| SI-BONE, Inc. | 20.24 Million USD | 98.074% |
| TELA Bio, Inc. | 13.16 Million USD | 97.036% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 98.666% |
| Vivos Therapeutics, Inc. | 1.00 USD | -39007500.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 90.882% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -69.598% |
| Nano-X Imaging Ltd. | 2.35 Million USD | 83.443% |
| CVRx, Inc. | 10.98 Million USD | 96.448% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Bioventus Inc. | 91.33 Million USD | 99.573% |
| Venus Concept Inc. | 28.67 Million USD | 98.64% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | 84.673% |
| LivaNova PLC | 147.88 Million USD | 99.736% |
| 908 Devices Inc. | 14.93 Million USD | 97.389% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 99.715% |
| Nemaura Medical Inc. | 1.75 Million USD | 77.772% |
| NeuroPace, Inc. | 11.21 Million USD | 96.522% |
| LENSAR, Inc. | 15.68 Million USD | 97.514% |
| Apyx Medical Corporation | 9.92 Million USD | 96.069% |
| Cutera, Inc. | 72.1 Million USD | 99.459% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | 85.407% |
| BioSig Technologies, Inc. | -103 Thousand USD | 478.715% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 99.159% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 95.069% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.9% |
| Axonics, Inc. | 79.94 Million USD | 99.512% |
| Outset Medical, Inc. | 49.21 Million USD | 99.207% |
| IRIDEX Corporation | 9.9 Million USD | 96.062% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 99.019% |
| IRadimed Corporation | 12.82 Million USD | 96.958% |
| Tivic Health Systems, Inc. | 756 Thousand USD | 48.403% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -47.473% |
| Telesis Bio, Inc. | 4.02 Million USD | 90.309% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 91.528% |
| Varex Imaging Corporation | 277.5 Million USD | 99.859% |
| Quipt Home Medical Corp. | 18.32 Million USD | 97.871% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 97.67% |
| Dynatronics Corporation | 5.59 Million USD | 93.027% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 89.573% |
| Semler Scientific, Inc. | 445 Thousand USD | 12.342% |
| InMode Ltd. | 45.09 Million USD | 99.135% |
| Bruker Corporation | 968.3 Million USD | 99.96% |
| Cytosorbents Corporation | 3.68 Million USD | 89.4% |
| DexCom, Inc. | 559.6 Million USD | 99.93% |
| Align Technology, Inc. | 296.9 Million USD | 99.869% |
| Viveve Medical, Inc. | 1.47 Million USD | 73.5% |
| ZimVie Inc. | 79.6 Million USD | 99.51% |
| Movano Inc. | 1.51 Million USD | 74.218% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 99.359% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -149.377% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 99.753% |
| Profound Medical Corp. | 6.95 Million USD | 94.39% |
| Insulet Corporation | 402.6 Million USD | 99.903% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 97.371% |
| iCAD, Inc. | 917 Thousand USD | 57.462% |
| Nuwellis, Inc. | 1.99 Million USD | 80.467% |
| Biotricity, Inc. | 1.87 Million USD | 79.245% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 97.208% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | 81.478% |
| PAVmed Inc. | 1.01 Million USD | 61.644% |
| BIOLASE, Inc. | 11.43 Million USD | 96.588% |
| Beyond Air, Inc. | 2.12 Million USD | 81.661% |
| FONAR Corporation | 2.71 Million USD | 85.635% |
| AxoGen, Inc. | 23.02 Million USD | 98.305% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 98.268% |
| Inari Medical, Inc. | 42.9 Million USD | 99.091% |
| UFP Technologies, Inc. | 70.19 Million USD | 99.444% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | 38.002% |
| Tenon Medical, Inc. | 554 Thousand USD | 29.589% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | 76.568% |
| AdaptHealth Corp. | 113.64 Million USD | 99.657% |
| Sintx Technologies, Inc. | 888 Thousand USD | 56.073% |
| NanoVibronix, Inc. | 2.73 Million USD | 85.722% |
| Quanterix Corporation | 22.36 Million USD | 98.256% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 97.373% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 99.312% |
| TransMedics Group, Inc. | 44.23 Million USD | 99.118% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 93.1% |
| NeuroMetrix, Inc. | 1.55 Million USD | 74.986% |
| Hyperfine, Inc. | 6.58 Million USD | 94.074% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 99.512% |
| Biomerica, Inc. | 2.37 Million USD | 83.583% |
| Bone Biologics Corporation | -328.84 Thousand USD | 218.62% |
| AVITA Medical, Inc. | 3.12 Million USD | 87.503% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 98.694% |